Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,011 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of Cytoreductive Nephrectomy in Metastatic Clear Cell Renal cell Carcinoma in the Era of immunotherapy: An Analysis of the National Cancer Database.
Zerdan MB, Niforatos S, Arunachalam S, Jamaspishvili T, Wong R, Bratslavsky G, Jacob J, Ross J, Shapiro O, Goldberg H, Basnet A. Zerdan MB, et al. Among authors: ross j. Clin Genitourin Cancer. 2024 Dec;22(6):102193. doi: 10.1016/j.clgc.2024.102193. Epub 2024 Aug 21. Clin Genitourin Cancer. 2024. PMID: 39276503
HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) study.
Ghelani GH, Zerdan MB, Jacob J, Spiess PE, Li R, Necchi A, Grivas P, Kamat A, Danziger N, Lin D, Huang R, Decker B, Sokol ES, Cheng L, Pavlick D, Ross JS, Bratslavsky G, Basnet A. Ghelani GH, et al. Among authors: ross js. Urol Oncol. 2023 Dec;41(12):486.e15-486.e23. doi: 10.1016/j.urolonc.2023.09.001. Epub 2023 Oct 9. Urol Oncol. 2023. PMID: 37821306 Free article.
Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2.
Posada JM, Yakirevich E, Kamat AM, Sood A, Jacob JM, Bratslavsky G, Grivas P, Spiess PE, Li R, Necchi A, Mega AE, Golijanin DJ, Pavlick D, Huang RSP, Lin D, Danziger N, Sokol ES, Sivakumar S, Ross JS, Cheng L. Posada JM, et al. Among authors: ross js. Mod Pathol. 2024 Mar;37(3):100424. doi: 10.1016/j.modpat.2024.100424. Epub 2024 Jan 12. Mod Pathol. 2024. PMID: 38219954
Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer.
Leary JB, Enright T, Bakaloudi DR, Basnet A, Bratslavsky G, Jacob J, Spiess PE, Li R, Necchi A, Kamat AM, Pavlick DC, Danziger N, Huang RSP, Lin DI, Cheng L, Ross J, Talukder R, Grivas P. Leary JB, et al. Among authors: ross j. Target Oncol. 2024 May;19(3):447-458. doi: 10.1007/s11523-024-01056-x. Epub 2024 Apr 3. Target Oncol. 2024. PMID: 38570422
Optimizing the Use of Next-Generation Sequencing Assays in Patients With Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat Panel.
Tateo V, Cigliola A, Mercinelli C, Agarwal N, Grivas P, Kamat AM, Gibb EA, Moschini M, Brausi M, Dyrskjøt L, Loriot Y, Gupta S, Colecchia M, Spiess PE, Ross JS, Necchi A. Tateo V, et al. Clin Genitourin Cancer. 2024 Aug;22(4):102091. doi: 10.1016/j.clgc.2024.102091. Epub 2024 Apr 10. Clin Genitourin Cancer. 2024. PMID: 38735133
9,011 results